SERUM METHYLMALONIC ACID AND TOTAL HOMOCYSTEINE IN PATIENTS WITH SUSPECTED COBALAMIN DEFICIENCY - A CLINICAL-STUDY BASED ON GASTROINTESTINAL HISTOPATHOLOGICAL FINDINGS
A. Lindgren et al., SERUM METHYLMALONIC ACID AND TOTAL HOMOCYSTEINE IN PATIENTS WITH SUSPECTED COBALAMIN DEFICIENCY - A CLINICAL-STUDY BASED ON GASTROINTESTINAL HISTOPATHOLOGICAL FINDINGS, American journal of hematology, 56(4), 1997, pp. 230-238
We compared the sensitivity and specificity of the two metabolite test
s, methylmalonic acid (MMA) and total homocysteine (Hcy) in serum, and
serum cobalamin (Cbl) in patients referred to our hospital because of
suspected cobalamin deficiency and a serum cobalamin value at the ref
erring unit <200 pmol/L. All 111 patients included were investigated u
sing upper gastrointestinal endoscopy with biopsy specimens taken from
the gastric and duodenal mucosa to find a morphological basis for cob
alamin malabsorption as well as the Schilling test for the validation
of the serum tests, All patients were treated with cobalamin and new b
lood samples were taken after 4 weeks. We found no difference in sensi
tivity and specificity between serum MMA, Hcy, and Cbl in identifying
patients with and without conditions compatible with cobalamin malabso
rption. Elevated serum MMA and Hey were also found in about 15% of the
group of patients with normal Schilling tests and without a morpholog
ical basis for cobalamin malabsorption, Moreover, most patients in thi
s group responded with decreased values of the metabolite tests follow
ing cobalamin treatment, suggesting that neither elevated metabolites
nor a decrease in these values following cobalamin treatment are speci
fic for cobalamin deficiency. (C) 1997 Wiley-Liss, Inc.